In the most recent Device Talk podcast, Jan de Backer, CEO of Fluidda, was interviewed about medtech’s essential role in the escalating war against COVID-19.
He explains how Fluidda’s proprietary Functional Respiratory Imaging technology – which recently received FDA clearance – will aid diagnosis and treatment of COVID-19.
Currently, Fluidda is putting a lot of effort into developing a predictive model based on baseline FRI parameters to determine the risk of a patient rapidly declining. This could save lives by early intervention, efficient use of ICU resources, and will accelerate the development of treatments.
DeviceTalks Weekly Podcast is created by MassDevice.com, the online business journal of the medical device industry.
Categorised in: Research / March 23, 2020 4:56 pm /Tags: Corona, COVID-19